NIO Inc. director Annabelle Yu Long filed a Form 4 on November 6, 2026, reporting the vesting of 85,803 restricted share units and the resulting acquisition of 85,803 American depositary shares at a price of $0.
NIO Inc. director Wen Yonggang filed a Form 4 on November 6, 2026, disclosing the vesting of 78,003 restricted share units and the acquisition of an equal number of American depositary shares at a price of $0.
Flywire Corp Chief Financial Officer Cosmin Pitigoi filed a Form 4 on November 6, 2026, disclosing the sale of 20,532 shares of Voting Common Stock on November 4, 2026, executed under a previously adopted Rule 10b5-1 trading plan.
Flywire Corp Chief Payments Officer Mohit Kansal filed a Form 4 on November 6, 2026, disclosing the sale of 6,053 shares of Voting Common Stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.
Christina M. Yarian, SVP and Chief Accounting Officer of Curbline Properties Corp., filed a Form 4 on November 6, 2026, disclosing the sale of 5,000 shares of common stock on November 4, 2026.
Bradley J. Peterson, Executive Vice President and Chief Information Officer of Nasdaq, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of 5,000 shares of Nasdaq common stock on November 4, 2026.
Anthony John Pompliano III, Chief Executive Officer and 10% owner of Silvia, Inc. (NASDAQ:SVIA), filed an amended statement of changes in beneficial ownership on November 6, 2026, correcting and supplementing a prior filing dated April 7, 2026, to include previously omitted shares and a …
Inflection Points Inc. filed an amended statement of changes in beneficial ownership with the SEC on November 6, 2026, correcting and supplementing its original April 7, 2026 filing to reflect shares received in the April 6, 2026 merger involving Silvia, Inc. (NASDAQ:SVIA).
Director Elliott Robinson filed a Form 4 with the SEC on November 6, 2026, disclosing sales of Hinge Health, Inc. (NYSE:HNGE) Class A Common Stock by affiliated Bessemer Venture Partners funds on November 4 and November 5, 2026.
Director Robert L. Zerbe MD of Vericel Corporation filed a statement of changes in beneficial ownership on November 6, 2026, reporting the exercise of stock options and the sale of common stock across two trading days, November 4 and November 5, 2026, pursuant to …